Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8458734rdf:typepubmed:Citationlld:pubmed
pubmed-article:8458734lifeskim:mentionsumls-concept:C0057317lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C0034788lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C1823153lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C0522536lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C2349976lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C1552644lld:lifeskim
pubmed-article:8458734lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8458734pubmed:issue1lld:pubmed
pubmed-article:8458734pubmed:dateCreated1993-4-29lld:pubmed
pubmed-article:8458734pubmed:abstractTextTo investigate the role of gamma/delta+ T cells in allograft rejection, we have studied the TCR phenotype and function of lymphocytes infiltrating rejecting, rejected, and nonrejecting human renal allografts. Two-color immunohistologic staining showed that 19% of rejecting biopsies and 40% of rejected nephrectomies had significant infiltration (> 10% of the total T-cell population) with gamma/delta+ T cells. No biopsies from nonrejecting kidneys showed > 10% gamma/delta+ T cells. Flow-cytometry analysis of T-cell populations expanded from rejecting and rejected allografts demonstrated that 33% of biopsy- and 40% of nephrectomy-derived populations had significant percentages (> 10%) of gamma/delta+ T cells. Six cell lines with increased numbers of gamma/delta+ T cells were tested for cytolytic activity against the NK target cell line K562 and compared with cytotoxic activity of exclusively alpha/beta T-cell populations. Lysis was noted by all gamma/delta+, but no gamma/delta-, populations. To confirm that the cytotoxicity of these gamma/delta+ T-cell populations was not MHC directed, one nephrectomy-derived population with 69% gamma/delta+ T cells by cytometry and > 50% by immunohistology was studied extensively. High levels of killing were seen against the NK targets K562 and Daudi as well as other malignant, benign, and third-party renal cell lines, but relevant alloantigen-expressing targets were not killed. Sterile cell sorting was used to isolate the gamma/delta+ T cells. The gamma/delta+ cells displayed enhanced killing of K562 while the gamma/delta- cells showed no cytolytic activity. Cytotoxicity mediated by gamma/delta+ T cells was also demonstrated against donor-derived, untransformed renal cells.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8458734pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8458734pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8458734pubmed:languageenglld:pubmed
pubmed-article:8458734pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8458734pubmed:citationSubsetIMlld:pubmed
pubmed-article:8458734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8458734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8458734pubmed:statusMEDLINElld:pubmed
pubmed-article:8458734pubmed:monthJanlld:pubmed
pubmed-article:8458734pubmed:issn0198-8859lld:pubmed
pubmed-article:8458734pubmed:authorpubmed-author:SanfilippoFFlld:pubmed
pubmed-article:8458734pubmed:authorpubmed-author:FinnO JOJlld:pubmed
pubmed-article:8458734pubmed:authorpubmed-author:IbrahimSSlld:pubmed
pubmed-article:8458734pubmed:authorpubmed-author:KirkA DADlld:pubmed
pubmed-article:8458734pubmed:authorpubmed-author:DawsonD VDVlld:pubmed
pubmed-article:8458734pubmed:issnTypePrintlld:pubmed
pubmed-article:8458734pubmed:volume36lld:pubmed
pubmed-article:8458734pubmed:ownerNLMlld:pubmed
pubmed-article:8458734pubmed:authorsCompleteYlld:pubmed
pubmed-article:8458734pubmed:pagination11-9lld:pubmed
pubmed-article:8458734pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:meshHeadingpubmed-meshheading:8458734-...lld:pubmed
pubmed-article:8458734pubmed:year1993lld:pubmed
pubmed-article:8458734pubmed:articleTitleCharacterization of T cells expressing the gamma/delta antigen receptor in human renal allografts.lld:pubmed
pubmed-article:8458734pubmed:affiliationDepartment of Microbiology and Immunology, Duke University Medical Center, Durham, NC 27710.lld:pubmed
pubmed-article:8458734pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8458734pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8458734pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8458734pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8458734lld:pubmed